ABUS vs GILD: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Gilead Sciences Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.21
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ABUS | GILD | Winner |
|---|---|---|---|
| Market Cap | $780.84M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | -0.6% | 0.0% | GILD |
| Gross Margin | -98.9% | 78.7% | GILD |
Analyze ABUS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or GILD a better investment?
Comparing ABUS and GILD: Arbutus Biopharma Corp has a market cap of $780.84M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and GILD?
ABUS (Arbutus Biopharma Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or GILD?
GILD has higher revenue growth at 0.0% vs -0.6% for ABUS.
Which company is more profitable: ABUS or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to -98.9% for ABUS.
Which is the larger company: ABUS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $780.84M for ABUS.
Should I buy ABUS or GILD in 2026?
Both ABUS and GILD have investment merit. ABUS trades at $4.21 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and GILD stock?
Key differences: Market Cap ($780.84M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-98.9% vs 78.7%).